A.-A. Dünne

569 total citations
17 papers, 415 citations indexed

About

A.-A. Dünne is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A.-A. Dünne has authored 17 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A.-A. Dünne's work include Head and Neck Cancer Studies (4 papers), Cancer Diagnosis and Treatment (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). A.-A. Dünne is often cited by papers focused on Head and Neck Cancer Studies (4 papers), Cancer Diagnosis and Treatment (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). A.-A. Dünne collaborates with scholars based in Germany, Switzerland and Italy. A.-A. Dünne's co-authors include Jochen A. Werner, B. M. Lippert, B. J. Folz, A. Ramaswamy, S. Bien, R. Rochels, J.A. Werner, J. Werner, Annette Ramaswamy and Tibor Görögh and has published in prestigious journals such as Cancer Research, European Archives of Oto-Rhino-Laryngology and Laboratory Animals.

In The Last Decade

A.-A. Dünne

17 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.-A. Dünne Germany 11 214 167 92 74 72 17 415
Nina Dhurandhar United States 9 192 0.9× 115 0.7× 57 0.6× 84 1.1× 82 1.1× 11 430
J Collignon Belgium 8 122 0.6× 77 0.5× 110 1.2× 31 0.4× 40 0.6× 19 332
Hans-J. Welkoborsky Germany 12 191 0.9× 82 0.5× 130 1.4× 35 0.5× 56 0.8× 16 367
Ali Razfar United States 13 347 1.6× 90 0.5× 133 1.4× 33 0.4× 72 1.0× 20 507
Shuang Shi China 18 256 1.2× 203 1.2× 124 1.3× 51 0.7× 63 0.9× 32 640
Thalita Santana Brazil 12 283 1.3× 245 1.5× 33 0.4× 110 1.5× 71 1.0× 28 493
O. H. Shaheen United Kingdom 14 188 0.9× 110 0.7× 141 1.5× 60 0.8× 154 2.1× 32 454
Mária Gődény Hungary 10 125 0.6× 105 0.6× 94 1.0× 28 0.4× 60 0.8× 38 333
G. Scaramellini Italy 11 284 1.3× 209 1.3× 282 3.1× 41 0.6× 120 1.7× 21 487
Paolo Balercia Italy 11 181 0.8× 78 0.5× 70 0.8× 35 0.5× 36 0.5× 42 362

Countries citing papers authored by A.-A. Dünne

Since Specialization
Citations

This map shows the geographic impact of A.-A. Dünne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.-A. Dünne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.-A. Dünne more than expected).

Fields of papers citing papers by A.-A. Dünne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.-A. Dünne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.-A. Dünne. The network helps show where A.-A. Dünne may publish in the future.

Co-authorship network of co-authors of A.-A. Dünne

This figure shows the co-authorship network connecting the top 25 collaborators of A.-A. Dünne. A scholar is included among the top collaborators of A.-A. Dünne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.-A. Dünne. A.-A. Dünne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ciruelos, Eva, Andreas Schneeweiß, Fabio Puglisi, et al.. (2012). Abstract OT1-1-02: A single-arm phase IIIb study of pertuzumab and trastuzumab with a taxane as first-line therapy for patients with HER2-positive advanced breast cancer (PERUSE). Cancer Research. 72(24_Supplement). OT1–1. 10 indexed citations
2.
Werner, J., Behfar Eivazi, B. J. Folz, & A.-A. Dünne. (2006). „State of the Art” zur Klassifikation, Diagnostik und Therapie von zervikofazialen Hämangiomen und vaskulären Malformationen. Laryngo-Rhino-Otologie. 85(12). 883–891. 25 indexed citations
3.
4.
Dünne, A.-A., et al.. (2003). Atypical mycobacterial tuberculosis--a diagnostic and therapeutic dilemma? Case reports and review of the literature.. PubMed. 57(1). 17–23. 2 indexed citations
5.
Røst, Therese H., et al.. (2003). Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas.. PubMed. 23(2B). 1565–73. 52 indexed citations
6.
Dünne, A.-A., Robert Mandić, A. Ramaswamy, et al.. (2003). Lymphogenic metastatic spread of auricular VX2 carcinoma in New Zealand white rabbits.. PubMed. 22(6A). 3273–9. 31 indexed citations
7.
Dünne, A.-A., et al.. (2003). Lymph node topography of the head and neck in New Zealand White rabbits. Laboratory Animals. 37(1). 37–43. 16 indexed citations
8.
Werner, J.A., B. M. Lippert, A.-A. Dünne, et al.. (2002). Epiglottopexy for the treatment of severe laryngomalacia. European Archives of Oto-Rhino-Laryngology. 259(9). 459–464. 34 indexed citations
9.
10.
Mandić, Robert, et al.. (2002). Variations of EGF-R surface expression in squamous cell carcinomas of the head and neck region.. PubMed. 21(5). 3413–8. 11 indexed citations
11.
Werner, Jochen A. & A.-A. Dünne. (2001). Value of Neck Dissection in Patients with Squamous Cell Carcinoma of Unknown Primary. Oncology Research and Treatment. 24(1). 16–20. 8 indexed citations
12.
Dünne, A.-A., S. Bien, B. J. Folz, & J.A. Werner. (2001). Standard variant venous dysplasia of the cerebellum in a patient suffering from Muenke's syndrome and tinnitus. Auris Nasus Larynx. 28(3). 249–252. 2 indexed citations
13.
Dünne, A.-A. & J.A. Werner. (2001). Stand der kontroversen Diskussion um die Pathogenese und Behandlung des chronischen Paukenergusses im Kindesalter. Laryngo-Rhino-Otologie. 80(1). 1–10. 4 indexed citations
14.
Werner, Jochen A., A.-A. Dünne, B. J. Folz, et al.. (2001). Current concepts in the classification, diagnosis and treatment of hemangiomas and vascular malformations of the head and neck. European Archives of Oto-Rhino-Laryngology. 258(3). 141–149. 120 indexed citations
15.
Werner, J.A., A.-A. Dünne, & B. M. Lippert. (2001). Die Neck-Dissection im Wandel der Zeit. Der Onkologe. 7(5). 522–532. 1 indexed citations
16.
Dünne, A.-A., Annette Ramaswamy, Benedikt J. Folz, et al.. (2001). Value of sentinel lymphonodectomy in head and neck cancer patients without evidence of lymphogenic metastatic disease. Auris Nasus Larynx. 28(4). 339–344. 36 indexed citations
17.
Werner, Jochen A., A.-A. Dünne, D. Brandt, et al.. (1999). Untersuchungen zum Stellenwert der Sentinel Lymphonodektomie bei Karzinomen des Pharynx und Larynx1. Laryngo-Rhino-Otologie. 78(12). 663–670. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nina Dhurandhar Breakdown of academic impact, for papers by J Collignon Breakdown of academic impact, for papers by Hans-J. Welkoborsky Breakdown of academic impact, for papers by Ali Razfar Breakdown of academic impact, for papers by Shuang Shi Breakdown of academic impact, for papers by Thalita Santana Breakdown of academic impact, for papers by O. H. Shaheen Breakdown of academic impact, for papers by Mária Gődény Breakdown of academic impact, for papers by G. Scaramellini Breakdown of academic impact, for papers by Paolo Balercia
Rankless by CCL
2026